Search Results

There are 13392 results for: content related to: Cellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics

  1. You have full text access to this OnlineOpen article
    The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by “on-demand” addition of plerixafor to granulocyte–colony-stimulating factor


    Volume 54, Issue 9, September 2014, Pages: 2325–2335, Tamara Girbl, Verena Lunzer, Richard Greil, Konrad Namberger and Tanja Nicole Hartmann

    Version of Record online : 28 MAR 2014, DOI: 10.1111/trf.12632

  2. You have free access to this content
    Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma

    Intervention Review

    The Cochrane Library

    Tim Hartmann, Kai Hübel, Ina Monsef, Andreas Engert and Nicole Skoetz

    Published Online : 20 OCT 2015, DOI: 10.1002/14651858.CD010615.pub2

  3. Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients


    Volume 54, Issue 5, May 2014, Pages: 1243–1250, Ville Varmavuo, Johanna Rimpiläinen, Hanne Kuitunen, Anne Nihtinen, Kaija Vasala, Maija Mikkola, Anu Kutila, Päivi Lehtonen, Taru Kuittinen, Pentti Mäntymaa, Tapio Nousiainen, Outi Kuittinen and Esa Jantunen

    Version of Record online : 30 SEP 2013, DOI: 10.1111/trf.12434

  4. Efficacy of just-in-time plerixafor rescue for Hodgkin's lymphoma patients with poor peripheral blood stem cell mobilization


    Volume 54, Issue 8, August 2014, Pages: 2015–2021, Shan Yuan, Auayporn Nademanee, Mark Kaniewski, Joycelynne Palmer, Sepideh Shayani and Shirong Wang

    Version of Record online : 24 MAR 2014, DOI: 10.1111/trf.12594

  5. You have full text access to this OnlineOpen article
    Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma


    Volume 55, Issue 2, February 2015, Pages: 275–283, Jian Cheng, Michael Schmitt, Patrick Wuchter, Eike C. Buss, Mathias Witzens-Harig, Kai Neben, Michael Hundemer, Jens Hillengass, Renate Alexi, Hartmut Goldschmidt, Bao-an Chen, Anthony D. Ho and Anita Schmitt

    Version of Record online : 13 AUG 2014, DOI: 10.1111/trf.12813

  6. You have free access to this content

    Vox Sanguinis

    Volume 109, Issue S1, June 2015, Pages: 1–379,

    Version of Record online : 19 JUN 2015, DOI: 10.1111/vox.12304

  7. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte–colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit–GM, engraftment, and Day +100 hematopoietic graft function


    Volume 51, Issue 9, September 2011, Pages: 1995–2000, Erin T. Alexander, Jeanne A. Towery, Ashley N. Miller, Cindy Kramer, Kathy R. Hogan, Jerry E. Squires, Robert K. Stuart and Luciano J. Costa

    Version of Record online : 10 MAR 2011, DOI: 10.1111/j.1537-2995.2011.03085.x

  8. Plerixafor and granulocyte–colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program


    Volume 51, Issue 5, May 2011, Pages: 968–975, Nina Worel, Konrad Rosskopf, Peter Neumeister, Hedwig Kasparu, David Nachbaur, Gudrun Russ, Konrad Namberger, Volker Witt, Ernst Schloegl, Niklas Zojer, Werner Linkesch, Peter Kalhs and Hildegard T. Greinix

    Version of Record online : 28 SEP 2010, DOI: 10.1111/j.1537-2995.2010.02896.x

  9. Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor

    Hematological Oncology

    Shan Yuan, Joycelynne M. Palmer, Ni-Chun Tsai, Andrew Dagis, Auayporn Nademanee and Shirong Wang

    Version of Record online : 29 FEB 2016, DOI: 10.1002/hon.2286

  10. Plerixafor as First- and Second-Line Strategies for Autologous Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma or Multiple Myeloma

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 7, July 2012, Pages: 596–603, Kevin W. Lor, Pieter J. Helmons, Helen Belew, James R. Lane and Edward D. Ball

    Version of Record online : 3 JUL 2012, DOI: 10.1002/j.1875-9114.2012.01096.x

  11. 2015 ASPHO Abstracts

    Pediatric Blood & Cancer

    Volume 62, Issue S2, June 2015, Pages: S21–S119,

    Version of Record online : 13 APR 2015, DOI: 10.1002/pbc.25540

  12. Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison


    Volume 55, Issue 10, October 2015, Pages: 2358–2368, Jaakko Valtola, Ville Varmavuo, Antti Ropponen, Anne Nihtinen, Anu Partanen, Kaija Vasala, Päivi Lehtonen, Karri Penttilä, Marja Pyörälä, Taru Kuittinen, Raija Silvennoinen, Tapio Nousiainen, Jukka Pelkonen, Pentti Mäntymaa and Esa Jantunen

    Version of Record online : 28 MAY 2015, DOI: 10.1111/trf.13170

  13. Special Issue Abstracts From the American Society for Apheresis 36th Annual Meeting, May 6–9, 2015 San Antonio, Texas

    Journal of Clinical Apheresis

    Volume 30, Issue 2, April 2015, Pages: 61–133,

    Version of Record online : 21 APR 2015, DOI: 10.1002/jca.21385

  14. The effective use of plerixafor as a real-time rescue strategy for patients poorly mobilizing autologous CD34+ cells

    Journal of Clinical Apheresis

    Volume 27, Issue 2, 2012, Pages: 81–87, Ajay K. Gopal, Mehdi Karami, JoAl Mayor, Mylene Macebeo, Michael Linenberger, William I. Bensinger and Leona Holmberg

    Version of Record online : 2 FEB 2012, DOI: 10.1002/jca.21206

  15. Blood graft lymphocyte subsets after plerixafor injection in non-Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte–colony-stimulating factor


    Volume 52, Issue 8, August 2012, Pages: 1785–1791, Ville Varmavuo, Pentti Mäntymaa, Taru Kuittinen, Tapio Nousiainen and Esa Jantunen

    Version of Record online : 5 FEB 2012, DOI: 10.1111/j.1537-2995.2011.03525.x

  16. Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept


    Volume 52, Issue 4, April 2012, Pages: 906–914, Esa Jantunen and Roberto M. Lemoli

    Version of Record online : 7 OCT 2011, DOI: 10.1111/j.1537-2995.2011.03349.x

  17. A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma


    Volume 53, Issue 1, January 2013, Pages: 76–84, Jonathan L. Kaufman, Christopher R. Flowers, Karen D. Rados, Gary B. Calandra, Julie M. Vose, L. Becker Hewes, Sagar Lonial, Amelia A. Langston, H. Jean Khoury, Mary Jo Lechowicz and Edmund K. Waller

    Version of Record online : 25 MAY 2012, DOI: 10.1111/j.1537-2995.2012.03719.x

  18. European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization


    Volume 52, Issue 11, November 2012, Pages: 2395–2400, Nina Worel, Jane F. Apperley, Grzegorz W. Basak, Kenneth W. Douglas, Ian H. Gabriel, Catarina Geraldes, Kai Hübel, Ozren Jaksic, Zdenek Koristek, Francesco Lanza, Roberto Lemoli, Gabor Mikala, Dominik Selleslag, Rafael F. Duarte and Mohamad Mohty

    Version of Record online : 13 MAR 2012, DOI: 10.1111/j.1537-2995.2012.03603.x

  19. SIOP 2015 Scientific Programme + Index

    Pediatric Blood & Cancer

    Volume 62, Issue S4, November 2015, Pages: S143–S418,

    Version of Record online : 9 SEP 2015, DOI: 10.1002/pbc.25715

  20. Pegfilgrastim- versus filgrastim-based autologous hematopoietic stem cell mobilization in the setting of preemptive use of plerixafor: efficacy and cost analysis


    Volume 52, Issue 11, November 2012, Pages: 2375–2381, Luciano J. Costa, Cindy Kramer, Kathy R. Hogan, Coleen D. Butcher, Amanda L. Littleton, Katie B. Shoptaw, Yubin Kang and Robert K. Stuart

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1537-2995.2012.03579.x